Abstract
Preliminary Data on a Phase 1/2A First in Human Study of the Menin-KMT2A (MLL) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have